Skip to Content

Equetro Approval History

FDA Approved: Yes (First approved December 10, 2004)
Brand name: Equetro
Generic name: carbamazepine
Dosage form: Extended-Release Capsules
Company: Shire Pharmaceuticals Group plc
Treatment for: Bipolar Disorder

Equetro (carbamazepine) is an extended-release anticonvulsant indicated for the treatment of acute manic and mixed episodes associated with Bipolar I Disorder.

Development History and FDA Approval Process for Equetro

DateArticle
Dec 10, 2004Approval Equetro Shire Pharmaceuticals Group plc - Treatment for Bipolar Disorder

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide